Papers

3

Total Citations

106

H-Index

3

About

Dr. Daniel Su is a urologic oncologist whose research focuses on improving the diagnosis, staging, and surgical treatment of prostate cancer. His work bridges advanced imaging and surgical outcomes, with a particular emphasis on the role of multiparametric MRI in risk stratification. In his most cited study, "Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis" (51 citations), Dr. Su demonstrated that the length of tumor contact with the prostatic capsule on MRI can serve as a non-invasive biomarker for extracapsular extension, offering a novel tool for preoperative planning and prognostication. He has also made significant contributions to comparative effectiveness research, as seen in his case-mix-adjusted analysis of open versus robotic prostatectomy (47 citations), which showed that experienced high-volume surgeons achieve comparable early oncological outcomes with either approach—a finding that informs surgical decision-making and patient counseling. Additionally, Dr. Su’s early work on the RoSS surgical simulator (8 citations) helped validate its use in residency training, advancing the field of simulation-based surgical education. His research has been cited over 100 times, reflecting its impact on both clinical practice and surgical training.

Research Focus

Key Achievements

3
H-Index
3
Papers
106
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis
51 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: National Institutes of Health, Department of Public Service, Johnson University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago